European Journal of Pharmacology 1991: Vol 202 Index

15 Pages·1991·5.3 MB·English

European Journal of Pharmacology, 202 (1991) 409-412
© 1991 Elsevier Science Publishers B.V. All rights reserved 0014-/2919 /9$039.5 0
Author index
Ahrén, B., see Karlsson, S. (202) 253 Corsini, G.U., see Del Zompo, M. (202) 293
Allen, M., see Sannerud, C.A. (202) 159 Couture, R., see Hasséssian, H. (202) 51
Arai, I., Hirose-Kijima, H., Usuki-Ito, C., Muramatsu, M. and Otomo,
S.
Daffonchio, L., Hernandez, A. and Omini, C.
Putative role of endogenous insulin in cysteamine-induced hyper-
Adrenaline-induced tracheal relaxation ex vivo is depressed fol-
secretion of gastric acid in rats (202) 213
lowing aerosol antigen challenge of sensitized guinea-pigs (202)
97
Barbieri, A., see Grana, E. (202) 93 Davis, J.M., see Pandey, S.C. (202) 221
Barthelmebs, M., see Grima, M. (202) 137 De Champlain, J., see Hasséssian, H. (202) 51
Bates, J.N., see Lewis, S.J. (202) 135 Delbende, C., Contesse, V., Mocaér, E., Kamoun, A. and Vaudry, H.
Ben-Shachar, D., Pinhassi, B. and Youdim, M.B.H. The novel antidepressant, tianeptine, reduces stress-evoked stim-
Prevention of neuroleptic-induced dopamine D, receptor super- ulation of the hypothalamo-pituitary-adrenal axis (202) 391
sensitivity by chronic iron salt treatment (202) 177
Del Zompo, M., Piccardi, M.P., Ruiu, S., Corsini, G.U. and Vaccari,
Bhargava, H.N., Gulati, A. and Rahmani, N.H. A.
Differences in the binding of [7H][D-Ser’,Thr°® Jleucine-enkepha-
High-affinity binding of [*H]1-methyl-4-phenyl-2,3-dihydropyri-
lin and [*H][D-Pen’,D-Pen>]enkephalin to brain membranes of dinium ion to mouse striatal membranes: putative vesicular loca-
morphine tolerant-dependent rats (202) 403 tion (202) 293
Bitterman, N., see Tzuk-Shina, T. (202) 171 De Mey, J.G.R., see Boonen, H.C.M. (202) 25
Boddeke, H.W.G.M. and Buttini, M. Diener, M., see Nobles, M. (202) 201
Pharmacological properties of cloned muscarinic receptors ex- Doods, H.N., see Post, M.J. (202) 67
pressed in A9 L cells; comparison with in vitro models (202) 151 Duncia, J.V., see Wong, P.C. (202) 323
Boer, R., see Eltze, M. (202) 33
Boja, J.W. and Schechter, M.D.
Eltze, M., Boer, R., Sanders, K.H. and Kolassa, N.
Possible serotonergic and dopaminergic mediation of the N-ethyl-
Vasodilatation elicited by 5-HT,, receptor agonists in constant-
3,4-methylenedioxyamphetamine discriminative stimulus (202) 347
pressure-perfused rat kidney is mediated by blockade of a,,-
Boonen, H.C.M. and De Mey, J.G.R.
adrenoceptors (202)°33
Effects of a phorbol ester and staurosporine on electro- and
Eto, T., see Kita, T. (202) 73
pharmacomechanical coupling in a resistance artery (202) 25
Evans, D.L., see Lahti, R.A. (202) 289
Borgers, M., see Vandeplassche, G. (202) 259
Exner, M., see Furmidge, L.J. (202) 191
Brown, E.E., Nomikos, G.G., Wilson, C. and Fibiger, H.C.
Chronic desipramine enhances the effect of locally applied am-
phetamine on interstitial concentrations of dopamine in the nu- ffrench-Mullen, J.M.H. and Spence, K.T.
cleus accumbens (202) 125 Neurosteroids block Ca** channel current in freshly isolated
Bruinvels, A.T., Landwehrmeyer, B., Waeber, C., Palacios, J.M. and hippocampal CA1 neurons (202) 269
Hoyer, D. Fibiger, H.C., see Brown, E.E. (202) 125
Homogeneous 5-HT,p recognition sites in the human substantia Figur, L.M., see Lahti, R.A. (202) 289
nigra identified with a new iodinated radioligand (202) 89 Fredholm, B.B., see Parkinson, F.E. (202) 361
Brutsaert, D.L., see Meulemans, A.L. (202) 45 Fujimoto, S. and Matsuda, T.
Buéno, L., see Martinez, J.A. (202) 379 M; cholinoceptors and P,, purinoceptors mediating relaxation of
Burleigh, D.E. arteries in spontaneously hypertensive rats at prehypertensive
stages (202) 9
Loperamide but not morphine has anti-secretory effects in hu-
Furman, B.L., see Guc, M.O. (202) 397
man colon, in vitro (202) 277
Buttini, M., see Boddeke, H.W.G.M. (202) 151 Furmidge, L.J., Exner, M. and Clark, D.
Role of dopamine D, and D, receptors in mediating the d-
amphetamine discriminative cue (202) 191
Carbone, R., see Maura, G. (202) 185
Furukawa, K., see Irie, K. (202) 285
Carrigan, K.J., see Lahti, R.A. (202) 289
Christie, M.I. and Lewis, M.J.
A comparison of endothelium-derived relaxing factor activity in Gaal, L., Schudt, C. and Illes, P.
the coronary and renal arteries of the pig (202) 143 Effects of phosphodiesterase inhibition on the excitability of
Clark, D., see Furmidge, L.J. (202) 191 hippocampal pyramidal neurons in vitro (202) 117
Coffin, V., see McHugh, D. (202) 133 Galli, C., see Lograno, M.D. (202) 311
Contesse, V., see Delbende, C. (202) 391 Grana, E., Barbieri, A. and Zonta, F.
Cook, J.M., see Sannerud, C.A. (202) 159 Inhibition by glibenclamide of the effects of cromakalim on
Cornfield, L.J. and Sills, M.A. responses of rat vas deferens to naphazoline (202) 93
High affinity interleukin-6 binding sites in bovine hypothalamus Grassi, G., see Lograno, M.D. (202) 311
(202) 113 Griffiths, R.R., see Sannerud, C.A. (202) 159
410
Grima, M., Michel, B., Barthelmebs, M., Stephan, D. and Imbs, J.-L. Karlsson, S. and Ahrén, B.
The effects of muzolimine and urine from muzolimine-treated CCK, receptor antagonism inhibits mechanisms underlying
rats on Na*K*Cl~ cotransport in Madin—Darby canine kidney CCK-8-stimulated insulin release in isolated rat islets (202) 253
cells (202) 137 Kida, O., see Kita, T. (202) 73
Grohs, J.G., see Huber, S. (202) 1 Kita, T., Kida, O., Yokota, N., Eto, T., Minamino, N., Kangawa, K..,
Guc, M.O., Furman, B.L. and Parratt, J.R. Matsuo, H. and Tanaka, K.
Endotoxin impairs the response of rat anococcygeus muscle to Effects of brain natriuretic peptide-45, a circulating form of rat
electrical field stimulation (202) 397 brain natriuretic peptide, in spontaneously hypertensive rats (202)
Guido, M., see Maura, G. (202) 185 73
Gulati, A., see Bhargava, H.N. (202) 403 Kogo, H., see Tamura, K. (202) 317
Kolassa, N., see Eltze, M. (202) 33
Komatsu, K., see Sasaki, Y. (202) 367
Hacksell, U., see Johansson, C.E. (202) 81
Hammer, Jr., R.P., see Margulies, J.E. (202) 373
Lahti, R.A., Evans, D.L., Figur, L.M., Carrigan, K.J., Moon, M.W.
Harel, D., see Tzuk-Shina, T. (202) 171
and Hsi, R.S.
Hart, S.D., see Wong, P.C. (202) 323
Dopamine D, receptor binding properties of [7HJU-86170, a
Hashimoto, A., Nishikawa, T., Oka, T. and Takahashi, K.
dopamine receptor agonist (202) 289
D-Alanine inhibits methamphetamine-induced hyperactivity in
Lajtha, A., see Térdcsik, A. (202) 297
rats (202) 105
Landwehrmeyer, B., see Bruinvels, A.T. (202) 89
Hasséssian, H., Prat, A., De Champlain, J. and Couture, R.
Lee, N.M., see Roy, S. (202) 355
Regulation of cardiovascular sympathetic neurons by substance P
Lewis, M.J., see Christie, M.I. (202) 143
and y-aminobutyric acid in the rat spinal cord (202) 51
Lewis, S.J., Ohta, H., Machado, B., Bates, J.N. and Talman, W.T.
Hernandez, A., see Daffonchio, L. (202) 97
Microinjection of S-nitrosocysteine into the nucleus tractus soli-
Hirose-Kijima, H., see Arai, I. (202) 213
tarii decreases arterial pressure and heart rate via activation of
Hogaboam, C.M. and Wallace, J.L.
soluble guanylate cyclase (202) 135
Inhibition of platelet aggregation by capsaicin. An effect unre-
Lograno, M.D., Mosconi, C., Marangoni, F., Medini, L., Grassi, G.
lated to actions on sensory afferent neurons (202) 129
and Galli, C.
Ho6nack, D., see Léscher, W. (202) 303
Vascular eicosanoids and platelet-aortic wall interactions in spon-
Hood, J.S., McMahon, T.J. and Kadowitz, P.J.
taneously hypertensive rats (202) 311
Influence of lemakalim on the pulmonary vascular bed of the cat
Loh, H.H., see Roy, S. (202) 355
(202) 101
Loscher, W., Rundfeldt, C. and Honack, D.
Hood, J.S., McMahon, T.J. and Kadowitz, P.J.
Tolerance to anticonvulsant effects of the partial benzodiazepine
Pulmonary vasodilator responses to RP 52891 are mediated by
receptor agonist abecarnil in kindled rats involves learning (202)
activation of a glibenclamide-sensitive K4+p channel (202) 121
303
Hornykiewicz, O., see Pifl, C. (202) 273
Hoyer, D., see Bruinvels, A.T. (202) 89
Machado, B., see Lewis, S.J. (202) 135
Hsi, R.S., see Lahti, R.A. (202) 289
Mansbach, R.S.
Huber, S., Grohs, J.G. and Raberger, G.
Effects of NMDA receptor ligands on sensorimotor gating in the
Cardiovascular and side effects of flesinoxan in conscious hyper-
rat (202) 61
tensive dogs. Modulation by prazosin (202) 1
Marangoni, F., see Lograno, M.D. (202) 311
Marchese, A., Mihic, S.J., Wu, P.H. and Kalant, H.
Illes, P., see Gaal, L. (202) 117 Arginine®-vasopressin potentiates the motor incoordinating ef-
Imbs, J.-L., see Grima, M. (202) 137 fects of pentobarbital (202) 341
Inomata, H., Ji, J.J., Mimata, T. and Yamagata, H. Margulies, J.E. and Hammer, Jr., R.P.
Concentration-related effects of extracellular application of ATP A’-Tetrahydrocannabinol alters cerebral metabolism in a bipha-
on the action potential and membrane currents of the guinea-pig sic, dose-dependent manner in rat brain (202) 373
vas deferens (202) 245 Martinez, J.A. and Buéno, L.
Irie, K., Muraki, T., Furukawa, K. and Nomoto, T. Buspirone inhibits corticotropin-releasing factor and stress-in-
L-N°-Nitro-arginine inhibits nicotine-induced relaxation of iso- duced cecal motor response in rats by acting through 5-HT,,
lated rat duodenum (202) 285 receptors (202) 379
Isaac, L., see Pandey, S.C. (202) 221 Matsuda, T., see Fujimoto, S. (202) 9
Matsuo, H., see Kita, T. (202) 73
Maura, G., Carbone, R., Guido, M., Pestarino, M. and Raiteri, M.
Jacobson, I., Pocock, G. and Richards, C.D.
5-HT, presynaptic receptors mediate inhibition of glutamate
Effects of pentobarbitone on the properties of nicotinic channels
release from cerebellar mossy fibre terminals (202) 185
of chromaffin cells (202) 331
McHugh, D. and Coffin, V.
Ji, J.J., see Inomata, H. (202) 245
The reversal of extrapyramidal side effects with SCH 39166, a
Johansson, C.E., Meyerson, B.J. and Hacksell, U.
dopamine D, receptor antagonist (202) 133
The novel 5-HT,, receptor antagonist (S)-UH-301 antagonizes
McMahon, T.J., see Hood, J.S. (202) 101
8-OH-DPAT-induced effects on male as well as female rat copu-
McMahon, T.J., see Hood, J.S. (202) 121
latory behaviour (202) 81
Medini, L., see Lograno, M.D. (202) 311
Meldrum, B.S., see Vasar, E. (202) 385
Kadowitz, P.J., see Hood, J.S. (202) 101 Meulemans, A.L. and Brutsaert, D.L.
Kadowitz, P.J., see Hood, J.S. (202) 121 Role of the endocardium in the inotropic action of UD-CG-212
Kalant, H., see Marchese, A. (202) 341 CL (202) 45
Kamoun, A., see Delbende, C. (202) 391 Meyerson, B.J., see Johansson, C.E. (202) 81
Kangawa, K., see Kita, T. (202) 73 Michel, B., see Grima, M. (202) 137
Mihic, S.J., see Marchese, A. (202) 341 Roy, S., Loh, H.H. and Lee, N.M.
Mimata, T., see Inomata, H. (202) 245 Dynorphin blocks opioid inhibition of macrophage-colony stimu-
Minamino, N., see Kita, T. (202) 73 lating factor-induced proliferation of bone marrow cells (202) 355
Mocaér, E., see Delbende, C. (202) 391 Ruiu, S., see Del Zompo, M. (202) 293
Moon, M.W., see Lahti, R.A. (202) 289 Rummel, W., see Nobles, M. (202) 201
Moriya, M., see Takayanagi, I. (202) 281 Rundfeldt, C., see Loscher, W. (202) 303
Mosconi, C., see Lograno, M.D. (202) 311
Motevalian, M., see Parsons, A.A. (202) 17 Sanders, K.H., see Eltze, M. (202) 33
Muraki, T., see Irie, K. (202) 285 Sannerud, C.A., Allen, M., Cook, J.M. and Griffiths, R.R.
Muramatsu, M., see Arai, I. (202) 213 Behavioral effects of benzodiazepine ligands in non-dependent,
diazepam-dependent and diazepam-withdrawn baboons (202) 159
Nemesy, K., see T6r6csik, A. (202) 297 Sasaki, Y., Seto, M., Komatsu, K. and Omura, S.
Nishikawa, T., see Hashimoto, A. (202) 105 Staurosporine, a protein kinase inhibitor, attenuates intracellular
Nobles, M., Diener, M. and Rummel, W. Ca**-dependent contractions of strips of rabbit aorta (202) 367
Segment-specific effects of the heat-stable enterotoxin of E. coli Schechter, M.D., see Boja, J.W. (202) 347
on electrolyte transport in the rat colon (202) 201 Schudt, C., see Gaal, L. (202) 117
Nomikos, G.G., see Brown, E.E. (202) 125 Sershen, H., see TOrdcsik, A. (202) 297
Nomoto, T., see Irie, K. (202) 285 Seto, M., see Sasaki, Y. (202) 367
Sills, M.A., see Cornfield, L.J. (202) 113
Oberfrank, F., see Tordcsik, A. (202) 297 Spence, K.T., see Ffrench-Mullen, J.M.H. (202) 269
Ohta, H., see Lewis, S.J. (202) 135 Stephan, D., see Grima, M. (202) 137
Oka, T., see Hashimoto, A. (202) 105 Stephenson, J.D., see Vasar, E. (202) 385
Okamoto, R., see Tamura, K. (202) 317
Okuma, Y. and Osumi, Y. Takahashi, K., see Hashimoto, A. (202) 105
Spinal cord substance P mediates the inhibition of gastric acid Takayanagi, I. and Moriya, M.
secretion induced by electrical stimulation of the preoptic area a,a-Adrenoceptors in rabbit bronchus (202) 281
(202) 227 Takeo, S., see Tamura, K. (202) 317
Omini, C., see Daffonchio, L. (202) 97 Talman, W.T., see Lewis, S.J. (202) 135
Omura, S., see Sasaki, Y. (202) 367 Tamura, K., Okamoto, R., Takeo, S. and Kogo, H.
Osumi, Y., see Okuma, Y. (202) 227 Inhibition of the first ovulation and ovarian prostaglandin F,,
Otomo, S., see Arai, I. (202) 213 metabolism by danazol in rats (202) 317
Tanaka, K., see Kita, T. (202) 73
Palacios, J.M., see Bruinvels, A.T. (202) 89 Te Biesebeek, J.D., see Post, M.J. (202) 67
Pandey, G.N., see Pandey, S.C. (202) 221 Thoné, F., see Vandeplassche, G. (202) 259
Pandey, S.C., Isaac, L., Davis, JM. and Pandey, G.N. Timmermans, P.B.M.W.M., see Wong, P.C. (202) 323
Similar effects of treatment with desipramine and electroconvul- Torocsik, A., Oberfrank, F., Sershen, H., Lajtha, A., Nemesy, K. and
sive shock on 5-hydroxytryptamine,, receptors in rat brain (202) Vizi, E.S.
221 Characterization of somatodendritic neuronal nicotinic receptors
Parkinson, F.E. and Fredholm, B.B. located on the myenteric plexus (202) 297
Effects of propentofylline on adenosine A, and A, receptors and Tvrdei¢, A. and Peri¢ci¢, D.
nitrobenzylthioinosine-sensitive nucleoside transporters: quanti- Dihydrogenated ergot compounds bind with high affinity to
tative autoradiographic analysis (202) 361 GABA , receptor-associated Cl~ ionophore (202) 109
Parratt, J.R., see Guc, M.O. (202) 397 Tzuk-Shina, T., Bitterman, N. and Harel, D.
Parsons, A.A., Motevalian, M. and Whalley, E.T. The effect of vigabatrin on central nervous system oxygen toxicity
Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and in rats (202) 171
flesinoxan in human isolated basilar artery (202) 17
Perici¢c, D., see Tvrdei¢é, A. (202) 109 Uhlén, S. and Wikberg, J.E.S.
Pestarino, M., see Maura, G. (202) 185 Delineation of rat kidney a@, - and a> p-adrenoceptors with
Piccardi, M.P., see Del Zompo, M. (202) 293 [>H]RX821002 radioligand binding: computer modelling reveals
Pifl, C., Reither, H. and Hornykiewicz, O. that guanfacine is an a>,-selective compound (202) 235
Lower efficacy of the dopamine D, agonist, SKF 38393, to Usuki-Ito, C., see Arai, I. (202) 213
stimulate adenylyl cyclase activity in primate than in rodent
striatum (202) 273 Vaccari, A., see Del Zompo, M. (202) 293
Pinhassi, B., see Ben-Shachar, D. (202) 177 Vandeplassche, G., Thoné, F. and Borgers, M.
Pocock, G., see Jacobson, I. (202) 331 Protective effects of R 56 865 against ischemic damage in the
Porsius, A.J., see Post, M.J. (202) 67 isolated rabbit heart (202) 259
Post, M.J., Te Biesebeek, J.D., Doods, H.N., Wemer, J., Van Rooij, Van Rooij, H.H., see Post, M.J. (202) 67
H.H. and Porsius, A.J. Vasar, E., Stephenson, J.D. and Meldrum, B.S.
Functional characterization of the muscarinic receptor in rat Changes in motor activity and forebrain [propionyl-*H]propi-
lungs (202) 67 onylated-CCK-8 binding in mice after repeated administration of
Prat, A., see Hasséssian, H. (202) 51 drugs affecting cholecystokinin receptors (202) 385
Vaudry, H., see Delbende, C. (202) 391
Raberger, G., see Huber, S. (202) 1 Vizi, E.S., see T6rdcsik, A. (202) 297
Rahmani, N.H., see Bhargava, H.N. (202) 403
Raiteri, M., see Maura, G. (202) 185 Waeber, C., see Bruinvels, A.T. (202) 89
Reither, H., see Pifl, C. (202) 273 Wallace, J.L., see Hogaboam, C.M. (202) 129
Richards, C.D., see Jacobson, I. (202) 331 Wemer, J., see Post, M.J. (202) 67
412
Whalley, E.T., see Parsons, A.A. (202) 17 Yamagata, H., see Inomata, H. (202) 245
Wikberg, J.E.S., see Uhlén, S. (202) 235 Yokota, N., see Kita, T. (202) 73
Wilson, C., see Brown, E.E. (202) 125 Youdim, M.B.H., see Ben-Shachar, D. (202) 177
Wong, P.C., Hart, $.D., Duncia, J.V. and Timmermans, P.B.M.W.M.
Nonpeptide angiotensin II receptor antagonists. Studies with
DuP 753 and EXP3174 in dogs (202) 323
Wu, P.H., see Marchese, A. (202) 341 Zonta, F., see Grana, E. (202) 93
European Journal of Pharmacology, 202 (1991) 413-421
© 1991 Elsevier Science Publishers B.V. All rights reserved 0014-/2919 /9$039.5 0
Key word index
Abecarnil AF-DX 116
Benzodiazepines; Tolerance; B-Carbolines (L6éscher, W. (202) 303) Muscarinic acetylcholine receptors; Purinoceptors; Pirenzepine; 4-
DAMP (4-diphenylacetoxy-N-methylpiperidine methobromide);
Abstinence a,B-Methylene ATP (Fujimoto, S. (202) 9)
Morphine; Tolerance—dependence; Brain regions; Spinal cord; DS-
TLE ({(D-Ser2,Thr° Jleucine-enkephalin); DPDPE ([D-Pen’,D-Pen*]- D-Alanine
enkephalin) (Bhargava, H.N. (202) 403) Methamphetamine; L-Alanine; Locomotor activity; Strychnine-insen-
sitive glycine binding site; NMDA receptor complex (Hashimoto, A.
Acetylcholine release (202) 105)
Nicotinic receptors; Nicotine; Dimethylphenylpiperazinium; Intesti-
L-Alanine
nal contraction (To6r6écsik, A. (202) 297)
Methamphetamine; D-Alanine; Locomotor activity; Strychnine-in-
sensitive glycine binding site; NMDA receptor complex (Hashimoto,
Acoustic startle
A. (202) 105)
NMDA (N-methyl-D-aspartate); Phencyclidine; Schizophrenia; NPC
12626; CGS 19755; Dizocilpine (Mansbach, R.S. (202) 61)
Ay L cells (mouse fibroblast)
Muscarinic receptors (cloned); Muscarinic M, receptors; Muscarinic
ACTH (adrenocorticotropic hormone)
M, receptors (Boddeke, H.W.G.M. (202) 151)
Corticosterone; Immobilization stress; 5-HT (5-hydroxytryptamine,
serotonin); Pituitary-adrenal axis; Tricyclic antidepressants; Tianep-
Amphetamine
tine (Delbende, C. (202) 391)
Desipramine; Dopamine; Microdialysis; Nucleus accumbens (Brown,
E.E. (202) 125)
Adenosine receptor antagonists
Hippocampal pyramidal cells; Field potentials; Phosphodiesterase
Caerulein; Devazepide; L-365,260; CCK receptors; Motor activity
inhibitors; B-Adrenoceptor agonists (Gaal, L. (202) 117) (Vasar, E. (202) 385)
Adenosine receptors d-Amphetamine discriminative cue
Nucleoside transport; Propentofylline; Autoradiography (Parkinson, Dopamine D, receptors; Dopamine D, receptors; Receptor interac-
F.E. (202) 361) tions; Dopamine receptor agonists; Dopamine receptor antagonists
(Furmidge, L.J. (202) 191)
Adenylyl cyclase
SK&F 38393; Dopamine D, receptors; Parkinson’s disease; (Rhesus Anaphylaxis
monkey); (Rat) (Pifl, C. (202) 273) Adrenaline responses; B-Adrenoceptors; Lung (guinea-pig) (Daf-
fonchio, L. (202) 97)
Adrenaline responses
B-Adrenoceptors; Anaphylaxis; Lung (guinea-pig) (Daffonchio, L. Angiotensin II receptor antagonists
Angiotension receptors; Antihypertensive agents; Renal functions;
(202) 97)
Renin-—angiotensin system; (Dog) (Wong, P.C. (202) 323)
B-Adrenoceptor agonists
Angiotension receptors
Hippocampal pyramidal cells; Field potentials; Phosphodiesterase
Angiotensin II receptor antagonists; Antihypertensive agents; Renal
inhibitors; Adenosine receptor antagonists (Gaal, L. (202) 117)
functions; Renin—angiotensin system; (Dog) (Wong, P.C. (202) 323)
a ,,-Adrenoceptors
Anococcygeus muscle (rat)
Bronchus (rabbit); WB4101; 5-Methylurapidil (Takayanagi, I. (202)
Endotoxin; L-Arginine pathway; (Electrical field stimulation) (Guc,
281)
M.O. (202) 397)
f -Adrenoceptors ANP (atrial natriuretic peptide)
Adrenaline responses; Anaphylaxis; Lung (guinea-pig) (Daffonchio,
BNP (brain natriuretic peptide); Blood pressure; Natriuresis;
L. (202) 97)
Metabolic clearance rate; (Rat) (Kita, T. (202) 73)
a ,-Adrenoceptor subtypes Antihypertensive agents
Kidney (perfused, rat); 5-HT,, receptor agonists; Vas deferens (rat) Angiotensin II receptor antagonists; Angiotension receptors; Renal
(Eltze, M. (202) 33) functions; Renin—angiotensin system; (Dog) (Wong, P.C. (202) 323)
a,-Adrenoceptor subtypes L-Arginine pathway
[>H]RX821002 radioligand binding; Computer modelling; Kidney; Endotoxin; Anococcygeus muscle (rat); (Electrical field stimulation)
(Rat) (Uhlén, S. (202) 235) (Guc, M.O. (202) 397)
414
Ataxia Ca?* channels
[Arg*vasopressin (AVP); Pentobarbital; Cl” uptake; GABA (y- Phorbol esters; Staurosporine; Excitation-contraction coupling
aminobutyric acid); (Rat) (Marchese, A. (202) 341) (Boonen, H.C.M. (202) 25)
ATP Ca’* currents
Vas deferens (guinea-pig); Ca** currents (voltage-dependent); Ce* Steroids; Hippocampus CA1 neurons; Picrotoxin; Patch clamp (whole
mobilization (intracellular) (Inomata, H. (202) 245) cell) (ffrench-Mullen, J.M.H. (202) 269)
Autoradiography Ca’* currents (voltage-dependent)
Adenosine receptors; Nucleoside transport; Propentofylline (Parkin- Vas deferens (guinea-pig); ATP; Ca** mobilization (intracellular)
son, F.E. (202) 361) (Inomata, H. (202) 245)
Benzodiazepines Caecum
Tolerance; Abecarnil; B-Carbolines (L6scher, W. (202) 303) 5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptors; Bus-
pirone; o receptors; CRF (corticotropin-releasing factor); Stress;
Blood pressure Intestinal motility; (Rat) (Martinez, J.A. (202) 379)
BNP (brain natriuretic peptide); ANP (atrial natriuretic peptide);
Natriuresis; Metabolic clearance rate; (Rat) (Kita, T. (202) 73) Caerulein
Devazepide; L-365,260; CCK receptors; Amphetamine; Motor activ-
BNP (brain natriuretic peptide) ity (Vasar, E. (202) 385)
ANP (atrial natriuretic peptide); Blood pressure; Natriuresis;
Metabolic clearance rate; (Rat) (Kita, T. (202) 73) Ca?* ionophores
Capsaicin; Platelets; Sensory afferent nerves; PAF (platelet-activat-
Bone marrow cells
ing factor, PAF-acether); Thrombin (Hogaboam, C.M. (202) 129)
Dynorphin; Morphine; M-CSF (macrophage-colony stimulating fac-
tor) (Roy, S. (202) 355)
Ca’** mobilization (intracellular)
Vas deferens (guinea-pig); ATP; Ca?* currents (voltage-dependent)
Bradykinin
(Inomata, H. (202) 245)
EDRF (endothelium-derived relaxing factor); Coronary artery; Re-
nal artery; Substance P (Christie, M.I. (202) 143)
Ca’* overload
R 56 865; Ischemia; Reperfusion; Heart (Vandeplassche, G. (202)
Brain
259)
Interleukin-6 (IL-6); Neuroimmunology; (Receptor) (Cornfield, L.J.
(202) 113)
Capsaicin
Platelets; Sensory afferent nerves; PAF (platelet-activating factor,
Cysteamine; Ulcer; Insulin; Gastric acid secretion; Glucose uptake;
PAF-acether); Thrombin; Ca** ionophores (Hogaboam, C.M. (202)
(Rat) (Arai, I. (202) 213)
129)
Brain (mouse)
B-Carbolines
Ergot alkaloids; [*H]JTBOB (t-[*H]butylbicycloorthobenzoate) bind-
Benzodiazepines; Tolerance; Abecarnil (Léscher, W. (202) 303)
ing; GABA , receptor complex (Tvrdei¢é, A. (202) 109)
Brain (rat) Cardiovascular responses
Substance P; GABA (y-aminobutyric acid); Spinal cord; Cate-
5-HT,, receptors; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)te-
cholamines; (Receptors) (Hasséssian, H. (202) 51)
tralin); Desipramine; Electroconvulsive shock (Pandey, S.C. (202)
221)
Catecholamines
Brain regions Substance P; GABA (y-aminobutyric acid); Spinal cord; Cardiovas-
Morphine; Tolerance—dependence; Abstinence; Spinal cord; DSTLE cular responses; (Receptors) (Hasséssian, H. (202) 51)
([D-Ser*,Thr°® Jleucine-enkephalin)} DPDPE ({D-Pen’,D-PeJne?n -
kephalin) (Bhargava, H.N. (202) 403) B-CCE (3-carboethoxy- B -carboline hydrochloride)
Diazepam; FG7142; Flumazenil; Midazolam; Dependence; GABA
Bronchoconstriction (y-aminobutyric acid); (Baboon) (Sannerud, C.A. (202) 159)
Muscarinic receptors; Histamine release; Lung (isolated); (Rat) (Post,
M.J. (202) 67) CCK-8 (cholecystokinin-8)
Insulin secretion; Islets; CCK, receptor antagonists; L-364,718;
Bronchus (rabbit) Ca**; K*; Phosphoinositide hydrolysis (Karlsson, S. (202) 253)
a,,-Adrenoceptors; WB4101; 5-Methylurapidil (Takayanagi, I. (202)
281) CCK, receptor antagonists
CCK-8 (cholecystokinin-8); Insulin secretion; Islets; L-364,718; Ca?*:
Buspirone K*; Phosphoinositide hydrolysis (Karlsson, S. (202) 253)
5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptors; 0 recep-
tors; CRF (corticotropin-releasing factor); Stress; Intestinal motility; CCK receptors
Caecum; (Rat) (Martinez, J.A. (202) 379) Caerulein; Devazepide; L-365,260; Amphetamine; Motor activity
(Vasar, E. (202) 385)
Ca*+
CCK-8 (cholecystokinin-8); Insulin secretion; Islets; CCK, receptor Cerebellum (rat)
antagonists; L-364,718; K*; Phosphoinositide hydrolysis (Karlsson, S. Mossy fibres; Glutamate release; 5-HT, receptors (presynaptic);
(202) 253) Synaptosomes; (Slices) (Maura, G. (202) 185)
415
Cerebral artery RP 52891; Pinacidil; KAy;p channels; Pulmonary vascular bed (Hood,
5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptors agonists; J.S. (202) 121)
5-HT,-like receptors; Sumatriptan; (Human) (Parsons, A.A. (202) 17)
M-CSF (macrophage-colony stimulating factor)
CGRP (calcitonin gene-related peptide) Bone marrow cells; Dynorphin; Morphine (Roy, S. (202) 355)
Lemakalim; Cromakalim; Pulmonary vascular bed; Glybenclamide-
sensitive channels; VIP (vasoactive intestinal polypeptide) (Hood, Cysteamine
J.S. (202) 101) Ulcer; Insulin; Gastric acid secretion; Glucose uptake; Brain; (Rat)
(Arai, I. (202) 213)
CGS 19755
NMDA (N-methyl-D-aspartate); Phencyclidine; Acoustic startle; 4-DAMP (4-diphenylacetoxy-N-methylpiperidine methobromide)
Schizophrenia; NPC 12626; Dizocilpine (Mansbach, R.S. (202) 61) Muscarinic acetylcholine receptors; Purinoceptors; Pirenzepine; AF-
DX 116; a,B-Methylene ATP (Fujimoto, S. (202) 9)
p-Chlorophenylalanine
MDE (N-ethyl-3,4-methylenedioxyamphetamine); MDMA (3,4-meth- Danazol
ylenedioxymethamphetamine); 5-HT (5-hydroxytryptamine, sero- Ovulation; Prostaglandin F,,; 13,14-Dihydroprostaglandin F,,
tonin); Dopamine; Drug discrimination (Boja, J.W. (202) 347) (Tamura, K. (202) 317)
Chlorpromazine 2-Deoxy-D-glucose
Dopamine D, receptor supersensitivity; Iron (Ben-Shachar, D. (202) A’-Tetrahydrocannabinol; Hippocampus; Limbic system; (Functional
177) activity) (Margulies, J.E. (202) 373)
Chromaffin cells (bovine) Dependence
Pentobarbitone; Nicotinic receptors; Ion channels; Patch clamp Diazepam; B-CCE (3-carboethoxy-B-carboline hydrochloride);
(Jacobson, I. (202) 331) FG7142; Flumazenil; Midazolam; GABA (y-aminobutyric acid);
(Baboon) (Sannerud, C.A. (202) 159)
Cl~ uptake
[Arg®]vasopressin (AVP); Ataxia; Pentobarbital; GABA (y- Desipramine
aminobutyric acid); (Rat) (Marchese, A. (202) 341) Dopamine; Amphetamine; Microdialysis; Nucleus accumbens
(Brown, E.E. (202) 125)
Colon
Morphine; Loperamide; Mucosa; Ion transport; (Human) (Burleigh, 5-HT,, receptors; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)te-
D.E. (202) 277) tralin); Electroconvulsive shock; Brain (rat) (Pandey, S.C. (202) 221)
Colon (rat) Devazepide
Enterotoxin of E. coli (heat-stable); Ion transport; Prostaglandins; Caerulein; L-365,260; CCK receptors; Amphetamine; Motor activity
cGMP.- inhibited phosphodiesterase (Nobles, M. (202) 201) (Vasar, E. (202) 385)
Computer modelling Diazepam
a,-Adrenoceptor subtypes; [>H]RX821002 radioligand binding; Kid- B-CCE (3-carboethoxy-B-carboline hydrochloride); FG7142; Flu-
ney; (Rat) (Uhlén, S. (202) 235) mazenil; Midazolam; Dependence; GABA (y-aminobutyric acid);
(Baboon) (Sannerud, C.A. (202) 159)
Copulatory behaviour
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Lordosis re- 13,14-Dihydroprostaglandin F,,
sponse; (S)-UH-301 ((S)-5-fluoro-8-hydroxy-2-(di-n-propylamino)te- Danazol; Ovulation; Prostaglandin F,, (Tamura, K. (202) 317)
tralin); (Rat) (Johansson, C.E. (202) 81)
Dimethylphenylpiperazinium
Coronary artery Nicotinic receptors; Nicotine; Acetylcholine release; Intestinal con-
EDRF (endothelium-derived relaxing factor); Renal artery; Brad- traction (T6récsik, A. (202) 297)
ykinin; Substance P (Christie, M.I. (202) 143)
Dizocilpine
Corticosterone NMDA (N-methyl-D-aspartate); Phencyclidine; Acoustic startle;
ACTH (adrenocorticotropic hormone); Immobilization stress; 5-HT Schizophrenia; NPC 12626; CGS 19755 (Mansbach, R.S. (202) 61)
(5-hydroxytryptamine, serotonin); Pituitary-adrenal axis; Tricyclic an-
tidepressants; Tianeptine (Delbende, C. (202) 391) Dopamine
Desipramine; Amphetamine; Microdialysis; Nucleus accumbens
CRF (corticotropin-releasing factor) (Brown, E.E. (202) 125)
5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptors; Bus-
pirone; o receptors; Stress; Intestinal motility; Caecum; (Rat) MDE (N-ethyl-3,4-methylenedioxyamphetamine); MDMA (3,4-meth-
(Martinez, J.A. (202) 379) ylenedioxymethamphetamine); 5-HT (5-hydroxytryptamine, sero-
tonin); p-Chlorophenylalanine; Drug discrimination (Boja, J.W. (202)
Cromakalim 347)
Vas deferens (rat); Naphazoline; Glibenclamide (Grana, E. (202) 93)
Dopamine receptor agonists
Lemakalim; Pulmonary vascular bed; Glybenclamide-sensitive chan- d-Amphetamine discriminative cue; Dopamine D, _ receptors;
nels; CGRP (calcitonin gene-related peptide); VIP (vasoactive in- Dopamine D, receptors; Receptor interactions; Dopamine receptor
testinal polypeptide) (Hood, J.S. (202) 101) antagonists (Furmidge, L.J. (202) 191)
416
Dopamine D, receptor agonists Endotoxin
G-proteins; (Cloned receptor) (Lahti, R.A. (202) 289) Anococcygeus muscle (rat); L-Arginine pathway; (Electrical field
stimulation) (Guc, M.O. (202) 397)
Dopamine receptor antagonists
Enterotoxin of E. coli (heat-stable)
d-Amphetamine discriminative cue; Dopamine Dy, _ receptors;
Dopamine D, receptors; Receptor interactions; Dopamine receptor Colon (rat); Ion transport; Prostaglandins; cGMP-inhibited phospho-
agonists (Furmidge, L.J. (202) 191) diesterase (Nobles, M. (202) 201)
Ergot alkaloids
Dopamine D, receptors
[7H]TBOB (t-[*H]butylbicycloorthobenzoate) binding; GABA, re-
d-Amphetamine discriminative cue; Dopamine D, receptors; Recep-
ceptor complex; Brain (mouse) (Tvrdei¢, A. (202) 109)
tor interactions; Dopamine receptor agonists; Dopamine receptor
antagonists (Furmidge, L.J. (202) 191)
Excitation-contraction coupling
Phorbol esters; Staurosporine; Ca** channels (Boonen, H.C.M. (202)
SK&F 38393; Adenylyl cyclase; Parkinson’s disease; (Rhesus mon-
25)
key); (Rat) (Pifl, C. (202) 273)
Exercise
Dopamine D, receptors
Flesinoxan; Prazosin; 5-HT,, receptor agonism; (Hypertensive dogs)
d-Amphetamine discriminative cue; Dopamine D, receptors; Recep-
(Huber, S. (202) 1)
tor interactions; Dopamine receptor agonists; Dopamine receptor
antagonists (Furmidge, L.J. (202) 191)
FG7142
Diazepam; B-CCE (3-carboethoxy-B-carboline hydrochloride);
Dopamine D, receptor supersensitivity Flumazenil; Midazolam; Dependence; GABA (y-aminobutyric acid);
Chlorpromazine; Iron (Ben-Shachar, D. (202) 177)
(Baboon) (Sannerud, C.A. (202) 159)
DPDPE ([{D-Pen”,D-Pen*]enkephalin)
Field potentials
Morphine; Tolerance—dependence; Abstinence; Brain regions; Spinal Hippocampal pyramidal cells; Phosphodiesterase inhibitors; B-
cord; DSTLE ({D-Ser?,Thr°]leucine-enkephalin) (Bhargava, H.N. Adrenoceptor agonists; Adenosine receptor antagonists (Gaal, L.
(202) 403) (202) 117)
Drug discrimination Flesinoxan
MDE (N-ethyl-3,4-methylenedioxyamphetamine); MDMA (3,4-meth- Prazosin; 5-HT,, receptor agonism; Exercise; (Hypertensive dogs)
ylenedioxymethamphetamine); 5-HT (5-hydroxytryptamine, sero- (Huber, S. (202) 1)
tonin); Dopamine; p-Chlorophenylalanine (Boja, J.W. (202) 347)
Flumazenil
DSTLE ([D-S°e] lreuc?ine,-eTnkehpharlin ) Diazepam; B-CCE (3-carboethoxy-B-carboline hydrochloride);
Morphine; Tolerance—dependence; Abstinence; Brain regions; Spinal FG7142; Midazolam; Dependence; GABA (y-aminobutyric acid);
cord; DPDPE ((D-Pen’,D-Pen*]enkephalin) (Bhargava, H.N. (202) (Baboon) (Sannerud, C.A. (202) 159)
403)
GABA (y-aminobutyric acid)
Substance P; Spinal cord; Cardiovascular responses; Catecholamines;
Duodenum (rat)
Nitric oxide (NO); Nicotine-induced relaxation (Irie, K. (202) 285) (Receptors) (Hasséssian, H. (202) 51)
Diazepam; B-CCE (3-carboethoxy-B-carboline hydrochloride);
Dynorphin
FG7142; Flumazenil; Midazolam; Dependence; (Baboon) (Sannerud,
Bone marrow cells; Morphine; M-CSF (macrophage-colony stimulat-
C.A. (202) 159)
ing factor) (Roy, S. (202) 355)
[Arg*Wwasopressin (AVP); Ataxia; Pentobarbital; Cl~ uptake; (Rat)
EDRF (endothelium-derived relaxing factor)
(Marchese, A. (202) 341)
Coronary artery; Renal artery; Bradykinin; Substance P (Christie,
M.I. (202) 143)
GABA, receptor complex
Ergot alkaloids; [7H]TBOB (t-[*H]butylbicycloorthobenzoate) bind-
EEG analysis
ing; Brain (mouse) (Tvrdei¢, A. (202) 109)
Oxygen toxicity; Generalized seizures; Vigabatrin; Hyperoxia; y-Vinyl
GABA (Tzuk-Shina, T. (202) 171)
Gastric acid secretion
Cysteamine; Ulcer; Insulin; Glucose uptake; Brain; (Rat) (Arai, I.
Electroconvulsive shock
(202) 213)
5-HT,, receptors; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)te-
tralin); Desipramine; Brain (rat) (Pandey, S.C. (202) 221)
Preoptic area; Substance P; Spinal cord; (Intrathecal injection);
(Desensitization) (Okuma, Y. (202) 227)
Endocardial endothelium
UD-CG-212-CL; Positive inotropic response; Myocardium (Meule- Generalized seizures
mans, A.L. (202) 45) Oxygen toxicity; Vigabatrin; Hyperoxia; EEG analysis; y-Vinyl GABA
(Tzuk-Shina, T. (202) 171)
Endothelin
Staurosporine; Protein kinase inhibitor; Prostaglandin F,,; Smooth Glibenclamide
muscle (Sasaki, Y. (202) 367) Vas deferens (rat); Naphazoline; Cromakalim (Grana, E. (202) 93)
Glucose uptake 5-HT,, receptors
Cysteamine; Ulcer; Insulin; Gastric acid secretion; Brain; (Rat) (Arai, 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Desipramine;
I. (202) 213) Electroconvulsive shock; Brain (rat) (Pandey, S.C. (202) 221)
Glutamate release 5-HT (5-hydroxytryptamine, serotonin); Buspirone; 0 receptors; CRF
Mossy fibres; Cerebellum (rat); 5-HT, receptors (presynaptic); (corticotropin-releasing factor); Stress; Intestinal motility; Caecum;
Synaptosomes; (Slices) (Maura, G. (202) 185) (Rat) (Martinez, J.A. (202) 379)
Glybenclamide-sensitive channels 5-HT,, receptors agonists
Lemakalim; Cromakalim; Pulmonary vascular bed; CGRP (calcitonin 5-HT (S-hydroxytryptamine, serotonin); 5-HT,-like receptors; Suma-
gene-related peptide); VIP (vasoactive intestinal polypeptide) (Hood, triptan; Cerebral artery; (Human) (Parsons, A.A. (202) 17)
J.S. (202) 101)
5-HT, receptors (presynaptic)
cGMP.-inhibited phosphodiesterase Mossy fibres; Cerebellum (rat); Glutamate release; Synaptosomes;
Enterotoxin of E. coli (heat-stable); Colon (rat); Ion transport; (Slices) (Maura, G. (202) 185)
Prostaglandins (Nobles, M. (202) 201)
5-HTp sites
G-proteins Substantia nigra (human); Serotonin-5-O-carboxymethyl-glycyl{!*I]-
Dopamine D, receptor agonists; (Cloned receptor) (Lahti, R.A. tyrosinamide (Bruinvels, A.T. (202) 89)
(202) 289)
Hyperoxia
Heart Oxygen toxicity; Generalized seizures; Vigabatrin; EEG analysis;
R 56 865; Ca** overload; Ischemia; Reperfusion (Vandeplassche, G. y-Vinyl GABA (Tzuk-Shina, T. (202) 171)
(202) 259)
Hypertension
Hippocampal pyramidal cells Platelet aggregation; Platelet thromboxane; Prostacyclin (aortic);
Field potentials; Phosphodiesterase inhibitors; B-Adrenoceptor ago- Platelet inhibition (by prostacyclin) (Lograno, M.D. (202) 311)
nists; Adenosine receptor antagonists (Gaal, L. (202) 117)
Immobilization stress
Hippocampus ACTH (adrenocorticotropic hormone); Corticosterone; 5-HT (5-hy-
A’-Tetrahydrocannabinol; 2-Deoxy-D-glucose; Limbic system; (Func- droxytryptamine, serotonin); Pituitary-adrenal axis; Tricyclic antide-
tional activity) (Margulies, J.E. (202) 373) pressants; Tianeptine (Delbende, C. (202) 391)
Hippocampus CAI neurons Insulin
Steroids; Ca?* currents; Picrotoxin; Patch clamp (whole cell) Cysteamine; Ulcer; Gastric acid secretion; Glucose uptake; Brain;
(ffrench-Mullen, J.M.H. (202) 269) (Rat) (Arai, I. (202) 213)
Histamine release Insulin secretion
Muscarinic receptors; Bronchoconstriction; Lung (isolated); (Rat) CCK-8 (cholecystokinin-8); Islets; CCK, receptor antagonists; L-
(Post, M.J. (202) 67) 364,718; Ca**; K*; Phosphoinositide hydrolysis (Karlsson, S. (202)
253)
5-HT (5-hydroxytryptamine, serotonin)
5-HT,, receptors agonists; 5-HT,-like receptors; Sumatriptan; Cere- Interleukin-6 (IL-6)
bral artery; (Human) (Parsons, A.A. (202) 17) Neuroimmunology; Brain; (Receptor) (Cornfield, L.J. (202) 113)
MDE (N-ethyl-3,4-methylenedioxyamphetamine); MDMA (3,4-meth- Intestinal contraction
ylenedioxymethamphetamine); Dopamine; p-Chlorophenylalanine; Nicotinic receptors; Nicotine; Dimethylphenylpiperazinium; Acetyl-
Drug discrimination (Boja, J.W. (202) 347) choline release (TOrécsik, A. (202) 297)
5-HT,, receptors; Buspirone; o receptors; CRF (corticotropin-re- Intestinal motility
leasing factor); Stress; Intestinal motility; Caecum; (Rat) (Martinez, 5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptors; Bus-
J.A. (202) 379) pirone; o receptors; CRF (corticotropin-releasing factor); Stress;
Caecum; (Rat) (Martinez, J.A. (202) 379)
ACTH (adrenocorticotropic hormone); Corticosterone; Immobiliza-
tion stress; Pituitary-adrenal axis; Tricyclic antidepressants; Tianep- Ion channels
tine (Delbende, C. (202) 391) Pentobarbitone; Chromaffin cells (bovine); Nicotinic receptors; Patch
clamp (Jacobson, I. (202) 331)
5-HT,-like receptors
5-HT (5-hydroxytryptamine, serotonin); 5-HT,, receptors agonists; Ion transport
Sumatriptan; Cerebral artery; (Human) (Parsons, A.A. (202) 17) Enterotoxin of E. coli (heat-stable); Colon (rat); Prostaglandins;
cGMP.-inhibited phosphodiesterase (Nobles, M. (202) 201)
5-HT,, receptor agonism
Flesinoxan; Prazosin; Exercise; (Hypertensive dogs) (Huber, S. (202) Morphine; Loperamide; Mucosa; Colon; (Human) (Burleigh, D.E.
1) (202) 277)
5-HT,, receptor agonists Iron
Kidney (perfused, rat); a,-Adrenoceptor subtypes; Vas deferens (rat) Dopamine D, receptor supersensitivity; Chlorpromazine (Ben-
(Eltze, M. (202) 33) Shachar, D. (202) 177)
418
Ischemia Lung (isolated)
R 56 865; Ca** overload; Reperfusion; Heart (Vandeplassche, G. Muscarinic receptors; Bronchoconstriction; Histamine release; (Rat)
(Post, M.J. (202) 67)
(202) 259)
MDCK cells
Islets
Na*K*Cl~ cotransport; Muzolimine; Loop diuretics (Grima, M.
CCK-8 (cholecystokinin-8); Insulin secretion; CCK, receptor antag-
onists; L-364,718; Ca?*; K*; Phosphoinositide hydrolysis (Karlsson, (202) 137)
S. (202) 253)
MDE (N-ethyl-3,4-methylenedioxyamphetamine )
MDMA (3,4-methylenedioxymethamphetamine); 5-HT (5-hydroxy-
K +
tryptamine, serotonin); Dopamine; p-Chlorophenylalanine; Drug dis-
CCK-8 (cholecystokinin-8); Insulin secretion; Islets; CCK, receptor
crimination (Boja, J.W. (202) 347)
antagonists; L-364,718; Ca**; Phosphoinositide hydrolysis (Karlsson,
S. (202) 253)
MDMA (3,4-methylenedioxymethamphetamine )
MDE (N-ethyl-3,4-methylenedioxyamphetamine); 5-HT (5-hydroxy-
K <yp channels
tryptamine, serotonin); Dopamine; p-Chlorophenylalanine; Drug dis-
RP 52891; Cromakalim; Pinacidil; Pulmonary vascular bed (Hood,
crimination (Boja, J.W. (202) 347)
J.S. (202) 121)
Metabolic clearance rate
Kidney BNP (brain natriuretic peptide); ANP (atrial natriuretic peptide);
a,-Adrenoceptor subtypes; [>H]RX821002 radioligand binding;
Blood pressure; Natriuresis; (Rat) (Kita, T. (202) 73)
Computer modelling; (Rat) (Uhlén, S. (202) 235)
Methamphetamine
Kidney (perfused, rat)
D-Alanine; L-Alanine; Locomotor activity; Strychnine-insensitive
5-HT,, receptor agonists; a,-Adrenoceptor subtypes; Vas deferens glycine binding site; NMDA receptor complex (Hashimoto, A. (202)
(rat) (Eltze, M. (202) 33) 105)
L-364,718 a,B-Methylene ATP
CCK-8 (cholecystokinin-8); Insulin secretion; Islets; CCK, receptor Muscarinic acetylcholine receptors; Purinoceptors; Pirenzepine; AF-
antagonists; Ca7*; K*; Phosphoinositide hydrolysis (Karlsson, S. DX 116; 4-DAMP (4-diphenylacetoxy-N-methylpiperidine methobro-
(202) 253) mide) (Fujimoto, S. (202) 9)
L-365,260 5-Methylurapidil
Caerulein; Devazepide; CCK receptors; Amphetamine; Motor activ- Bronchus (rabbit); a, ,-Adrenoceptors; WB4101 (Takayanagi, I. (202)
ity (Vasar, E. (202) 385) 281)
Lemakalim Microdialysis
Cromakalim; Pulmonary vascular bed; Glybenclamide-sensitive chan- Desipramine; Dopamine; Amphetamine; Nucleus accumbens (Brown,
nels; CGRP (calcitonin gene-related peptide); VIP (vasoactive in- E.E. (202) 125)
testinal polypeptide) (Hood, J.S. (202) 101)
Midazolam
Diazepam; B-CCE (3-carboethoxy-B-carboline hydrochloride);
Limbic system
FG7142; Flumazenil; Dependence; GABA (y-aminobutyric acid);
A’-Tetrahydrocannabinol; 2-Deoxy-D-glucose; Hippocampus; (Func-
(Baboon) (Sannerud, C.A. (202) 159)
tional activity) (Margulies, J.E. (202) 373)
Morphine
Locomotor activity
Loperamide; Mucosa; Ion transport; Colon; (Human) (Burleigh, D.E.
Methamphetamine; D-Alanine; L-Alanine; Strychnine-insensitive
(202) 277)
glycine binding site; NMDA receptor complex (Hashimoto, A. (202)
105)
Bone marrow cells; Dynorphin; M-CSF (macrophage-colony stimu-
lating factor) (Roy, S. (202) 355)
Loop diuretics
Na* K* Cl” cotransport; MDCK cells; Muzolimine (Grima, M. (202)
Tolerance—dependence; Abstinence; Brain regions; Spinal cord; DS-
137)
TLE ((D-Ser?,Thr®]leucine-enkephalin); DPDPE ({D-Pen?,D-
Pen°J enkephalin) (Bhargava, H.N. (202) 403)
Loperamide
Morphine; Mucosa; Ion transport; Colon; (Human) (Burleigh, D.E.
Mossy fibres
(202) 277) Cerebellum (rat); Glutamate release; 5-HT, receptors (presynaptic);
Synaptosomes; (Slices) (Maura, G. (202) 185)
Lordosis response
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Copulatory Motor activity
behaviour; (S)-UH-301 ((S)-5-fluoro-8-hydroxy-2-(di-n-propylamino)- Caerulein; Devazepide; L-365,260; CCK receptors; Amphetamine
tetralin); (Rat) (Johansson, C.E. (202) 81) (Vasar, E. (202) 385)
Lung (guinea-pig) Mucosa
Adrenaline responses; B-Adrenoceptors; Anaphylaxis (Daffonchio, Morphine; Loperamide; Ion transport; Colon; (Human) (Burleigh,
L. (202) 97) D.E. (202) 277)